A synthetic peptide for use as a blocking control in assays to test for specificity of BMP6 antibody, Alternative Names: BMP6 control peptide, BMP6 antibody Blocking Peptide, Anti-BMP6 Blocking Peptide, bone morphogenetic protein 6 Blocking Peptide, VGR Blocking Peptide, VGR1 Blocking Peptide, BMP6, BMP-6, BMP 6, BMP-6 Blocking Peptide, BMP 6 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
BMP6
(Bone Morphogenetic Protein 6 (BMP6))
Synonyme
BMP6 Peptide, zgc:113595 Peptide, vgr Peptide, vgr-1 Peptide, vgr1 Peptide, VGR Peptide, VGR1 Peptide, D13Wsu115e Peptide, Vgr1 Peptide, bone morphogenetic protein 6 Peptide, bone morphogenetic protein 6 S homeolog Peptide, BMP6 Peptide, bmp6 Peptide, bmp6.S Peptide, Bmp6 Peptide
Hintergrund
The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. Based on its expression early in embryogenesis, the BMP encoded by this gene has a proposed role in early development. In addition, the fact that this BMP is closely related to BMP5 and BMP7 has lead to speculation of possible bone inductive activity.